The development of specific inhibitors generally follows a multi-step process:
1. Identification of Target: Researchers first identify a molecular target, such as a protein or gene, that is crucial for cancer cell survival. 2. Drug Design: Using computational modeling and other technologies, scientists design molecules that can specifically bind to the target and inhibit its function. 3. Preclinical Testing: Potential inhibitors are tested in cell lines and animal models to evaluate their efficacy and safety. 4. Clinical Trials: Promising candidates proceed to clinical trials, where they are tested in humans to determine their effectiveness and safety.
